The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2004.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Life Science, Genetics. Among the various public portfolio startups of the fund, we may underline Genizon BioSciences
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the MVI Finance, startups are often financed by HBM Healthcare Investments AG, Biotech Turnaround Fund (BTF), BioFund Management. The meaningful sponsors for the fund in investment in the same round are HBM Healthcare Investments AG, Carnegie Asset Management, Biotech Turnaround Fund (BTF). In the next rounds fund is usually obtained by HBM Healthcare Investments AG, Biotech Turnaround Fund (BTF), BioFund Management.
Related Funds
| Fund Name | Location |
| AEON Financial | Chiyoda, Japan |
| Atreides Management, LP | Boston, Massachusetts, United States |
| BOOST Programs | France, Ile-de-France, Paris |
| Digital Education | England, London, United Kingdom |
| FirePower Capital | Canada, Ontario, Toronto |
| FounDream | Beijing, Beijing, China |
| Franklin Capital Corporation | Salt Lake City, United States, Utah |
| Green Partners Asset Management | - |
| Halestreet Investments | - |
| IMAX | Canada, Mississauga, Ontario |
| OVO | Indonesia, Jakarta, Jakarta Raya |
| Pangaea Asset Management | Chicago, Illinois, United States |
| RSBC | - |
| SE Energi & Klima | Denmark, Esbjerg, Region of Southern Denmark |
| Sputnik Capital | Barcelona, Catalonia, Spain |
| Thyme | - |
| TomorrowVentures | California, Palo Alto, United States |
| TOP Funds | - |
| University of Antwerp | Antwerp, Antwerpen, Belgium |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Genizon BioSciences | $8M | 13 Dec 2004 | Montreal, Quebec, Canada |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Genizon BioSciences | $8M | 13 Dec 2004 | Montreal, Quebec, Canada |
